These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 20838230)

  • 1. Pharmacologic and pharmacokinetic rationale for combination therapy in pulmonary arterial hypertension.
    Gokhman R; Smithburger PL; Kane-Gill SL; Seybert AL
    J Cardiovasc Pharmacol; 2010 Dec; 56(6):686-95. PubMed ID: 20838230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostacyclin therapy for pulmonary arterial hypertension: new directions.
    Gomberg-Maitland M; Preston IR
    Semin Respir Crit Care Med; 2005 Aug; 26(4):394-401. PubMed ID: 16121316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for the use of combination targeted therapeutic approaches for the management of pulmonary arterial hypertension.
    O'Callaghan DS; Savale L; Jaïs X; Natali D; Montani D; Humbert M; Simonneau G; Sitbon O
    Respir Med; 2010 Jul; 104 Suppl 1():S74-80. PubMed ID: 20418081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New and future therapies in pulmonary arterial hypertension.
    Bull TM
    Semin Respir Crit Care Med; 2005 Aug; 26(4):429-36. PubMed ID: 16121320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy for the treatment of pulmonary arterial hypertension.
    Levinson AT; Klinger JR
    Ther Adv Respir Dis; 2011 Dec; 5(6):419-30. PubMed ID: 21849335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combination treatment in pulmonary arterial hypertension].
    Kramer MR
    Harefuah; 2011 Apr; 150(4):383-8, 417. PubMed ID: 22164922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhaled epoprostenol for the treatment of pulmonary arterial hypertension in critically ill adults.
    Buckley MS; Feldman JP
    Pharmacotherapy; 2010 Jul; 30(7):728-40. PubMed ID: 20575636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical considerations for the pharmacotherapy of pulmonary arterial hypertension.
    Bishop BM; Mauro VF; Khouri SJ
    Pharmacotherapy; 2012 Sep; 32(9):838-55. PubMed ID: 22806762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-front combination therapy in pulmonary arterial hypertension: from clinical trials to 'real world' observational studies.
    Grignola JC
    Int J Cardiol; 2014 May; 173(3):349-50. PubMed ID: 24698227
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of pulmonary arterial hypertension with a focus on combination therapies.
    Benza RL; Park MH; Keogh A; Girgis RE
    J Heart Lung Transplant; 2007 May; 26(5):437-46. PubMed ID: 17449411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary arterial hypertension.
    Murali S
    Curr Opin Crit Care; 2006 Jun; 12(3):228-34. PubMed ID: 16672782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy with prostacyclin and tadalafil for severe pulmonary arterial hypertension: a pilot study.
    Bendayan D; Shitrit D; Kramer MR
    Respirology; 2008 Nov; 13(6):916-8. PubMed ID: 18811891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Combination therapy].
    Okano Y
    Nihon Rinsho; 2008 Nov; 66(11):2162-7. PubMed ID: 19051737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current treatment strategies for pulmonary arterial hypertension.
    Lee SH; Rubin LJ
    J Intern Med; 2005 Sep; 258(3):199-215. PubMed ID: 16115293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
    Barst R
    Int J Clin Pract Suppl; 2010 Nov; (168):23-32. PubMed ID: 20939843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of oral sildenafil as rescue therapy in patients with severe pulmonary arterial hypertension chronically treated with prostacyclin. Long-term results].
    Jiménez López-Guarch C; Escribano Subias P; Tello de Meneses R; Delgado Jiménez JF; Sadia Pérez D; Velázquez Martín MT; Gómez Sánchez MA; Sáenz de la Calzada C
    Rev Esp Cardiol; 2004 Oct; 57(10):946-51. PubMed ID: 15469792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of transition from intravenous epoprostenol to oral/inhaled targeted pulmonary arterial hypertension therapy in pediatric idiopathic and familial pulmonary arterial hypertension.
    Melnick L; Barst RJ; Rowan CA; Kerstein D; Rosenzweig EB
    Am J Cardiol; 2010 May; 105(10):1485-9. PubMed ID: 20451700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary arterial hypertension: on the way to a manageable disease.
    Mucke HA
    Curr Opin Investig Drugs; 2008 Sep; 9(9):957-62. PubMed ID: 18729002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compelling evidence of long-term outcomes in pulmonary arterial hypertension? A clinical perspective.
    Gomberg-Maitland M; Dufton C; Oudiz RJ; Benza RL
    J Am Coll Cardiol; 2011 Mar; 57(9):1053-61. PubMed ID: 21349396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacotherapeutic management of pulmonary arterial hypertension.
    Anderson JR; Nawarskas JJ
    Cardiol Rev; 2010; 18(3):148-62. PubMed ID: 20395700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.